Moderna said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine market. In a ...
Moderna’s flu shot could change the stock debate ...
U.S. pharmaceutical company Moderna is interested in investing in production facilities in Germany, with an eye on ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After donating $176 million in ...
Talk about a quick dash after securing the cash! On Wednesday, pharmaceutical company Moderna announced that its CFO Jorge Gomez left after only one day on the job — but he’ll still be collecting his ...
As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results